CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
Following its successful contribution to the American Association of Equine Practitioners-led project focused on locomotion ...
AliveCor (San Francisco) reported that the FDA has granted clearance for two new algorithms giving users instant feedback on their electrocardiogram (ECG) recordings and expanding its automated ...
A new clinical study shows that PulseAI’s deep learning AI demonstrates superiority over the Apple Watch ECG in the detection of atrial fibrillation. Results have been accepted for presentation at the ...
San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...
Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced ...
The latest beta of Apple Watch watchOS 7.2 has added a new version of Apple's ECG monitoring system's algorithm, seemingly the first revision since the original. Within the latest beta of forthcoming ...
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results